南财智讯12月18日电，毕得医药公告，公司股东李怡静、陈俊、李黎、杜鹃、李爱飞、耿勇、蒋亚妹合 计减持公司股份437,902股，占公司总股本的0.48%。本次减持计划时间区间已届满，减持方式均为集中 竞价交易。上述股东在减持前合计持有公司1.64%的股份，减持完成后持股比例相应减少。本次实际减 持情况与此前披露的减持计划一致，未设置最低减持数量和比例，不存在违反承诺的情况。 ...

第3笔成交价格为60.00元，成交3.34万股，成交金额200.40万元，溢价率为-7.25%，买方营业部为瑞银 证券有限责任公司上海花园石桥路证券营业部，卖方营业部为浙商证券股份有限公司上海长乐路证券营 业部。 进一步统计，近3个月内该股累计发生13笔大宗交易，合计成交金额为6055.01万元。该股近5个交易日 累计下跌3.45%，主力资金合计净流出501.35万元。 责任编辑：小浪快报 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 12月18日，毕得医药收跌1.57%，收盘价为64.69元，发生3笔大宗交易，合计成交量16.74万股，成交金 额1004.4万元。 第1笔成交价格为60.00元，成交10.00万股，成交金额600.00万元，溢价率为-7.25%，买方营业部为广发 证券股份有限公司总部，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。 第2笔成交价格为60.00元，成交3.40万股，成交金额204.00万元，溢价率为-7.25%，买方营业部为机构 专用，卖方营业部为浙商证券股份有限公司上海长乐路证券营业部。 ...

| 交易日期 | 证券简称 | 证券代码 | | | 成交价(元) 成交金额(万元) 成交量(*) 买入营业部 | | 类出营业部 | 是否为专场 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-12-18 | 毕得医药 | 688073 | 60 | 600 | 10 | 公司总裁 | ្នកនិងចំនួន | Ka | | 2025-12-18 | 毕得医药 | 688073 | 60 | 204 | 3.4 | 机构专用 | ្នុងក្រុងស្រុក | KA | | 2025-12-18 | 毕得医药 | 688073 | 60 | 200.4 | 3.34 | ី និង ខេត្តនៃម | 茶園正常送茶屋 | KO | 12月18日，毕得医药大宗交易成交16.74万股，成交额1004.4万元，占当日总成交额的32%，成交价60 元，较市场收盘价64.69元折价7.25%。 ...

Group 1 - A total of 78 stocks in the A-share market experienced block trading today, with a total transaction value of 3.755 billion yuan [1] - The top three stocks by transaction value were Minsheng Bank (2.149 billion yuan), WuXi AppTec (430 million yuan), and Luxin Technology (119 million yuan) [1] - Among the stocks, 8 were traded at par, 3 at a premium, and 67 at a discount; the highest premium rates were for AVIC Optoelectronics (8.04%), Zhongke Shuguang (7.92%), and Haowei Group (2.07%) [1] Group 2 - The top buying amounts from institutional special seats were led by WuXi AppTec (251 million yuan) and Minsheng Bank (108 million yuan) [2] - The top selling amounts from institutional special seats included Jintian Titanium Industry (18.74 million yuan) and Huilong New Materials (9.97 million yuan) [2]

Group 1 - On December 16, Bid Pharma executed a block trade of 47,900 shares, with a transaction value of 2.9698 million yuan, accounting for 8.14% of the total trading volume for the day [1] - The transaction price was 62 yuan, representing a discount of 4.44% compared to the market closing price of 64.88 yuan [1]

证券代码：688073 证券简称：毕得医药 公告编号：2025-089 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东会召开的时间：2025 年 12 月 10 日 （二） 股东会召开的地点：上海市杨浦区翔殷路 999 号 3 幢 6 层会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： 上海毕得医药科技股份有限公司 2025年第五次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 1、 公司在任董事6人，出席6人； 2、 董事会秘书王轩出席会议；副总经理张锐豪、财务总监王坤列席会议。 | 1、出席会议的股东和代理人人数 | 36 | | --- | --- | | 普通股股东人数 | 36 | | 2、出席会议的股东所持有的表决权数量 | 38,563,838 | | 普通股股东所持有表决权数量 | 38,563,838 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 44.7622 | | 例 ...

北京市东城区建国门内大街 26 号新闻大厦 7 层、8 层 电话：010-88004488/66090088 传真：010-66090016 邮编：100005 北京国枫律师事务所 关于上海毕得医药科技股份有限公司 2025 年第五次临时股东会的 法律意见书 国枫律股字[2025]A0596 号 致：上海毕得医药科技股份有限公司（贵公司） 北京国枫律师事务所（以下简称"本所"）接受贵公司的委托，指派律师出席并见 证贵公司 2025 年第五次临时股东会（以下简称"本次会议"）。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》（以下简称 "《股东会规则》"）、《律师事务所从事证券法律业务管理办法》（以下简称"《证 券法律业务管理办法》"）、《律师事务所证券法律业务执业规则（试行）》（以下简 称"《证券法律业务执业规则》"）等相关法律、行政法规、规章、规范性文件及《上 海毕得医药科技股份有限公司章程》（以下简称"《公司章程》"）的规定，就本次会 议的召集与召开程序、召集人资格、出席会议人员资格、会议表决程序及表决结果等事 ...

Market Performance - The medical services sector increased by 0.51% on December 8, with Chengdu XianDao leading the gains [1] - The Shanghai Composite Index closed at 3924.08, up 0.54%, while the Shenzhen Component Index closed at 13329.99, up 1.39% [1] Top Gainers in Medical Services - Chengdu XianDao (688222) closed at 23.20, up 1.75% with a trading volume of 45,700 shares and a turnover of 106 million yuan [1] - Other notable gainers include: - Guangzheng Eye Hospital (002524) at 4.63, up 1.54% [1] - MediXis (688202) at 53.96, up 1.35% [1] - WuXi AppTec (603259) at 91.55, up 1.27% with a significant turnover of 3.33 billion yuan [1] Top Losers in Medical Services - ST Zhongzhu (600568) closed at 2.79, down 2.11% with a trading volume of 614,600 shares and a turnover of 173 million yuan [2] - Other notable losers include: - Haoyuan Pharmaceutical (688131) at 74.35, down 1.50% [2] - Aoyang Health (002172) at 4.20, down 1.41% [2] Capital Flow Analysis - The medical services sector experienced a net outflow of 297 million yuan from institutional investors, while retail investors saw a net inflow of 317 million yuan [2][3] - Notable capital flows include: - WuXi AppTec (603259) with a net outflow of 30.81 million yuan from institutional investors [3] - NuoSiGe (301333) with a net inflow of 11.54 million yuan from institutional investors [3]

2025 年 12 月 上海毕得医药科技股份有限公司 2025 年第五次临时股东会会议资料 证券代码：688073 证券简称：毕得医药 上海毕得医药科技股份有限公司 2025 年第五次临时股东会会议资料 | 2025 | 年第五次临时股东会会议须知 1 | | --- | --- | | 2025 年第五次临时股东会会议议程 | 3 | | 2025 年第五次临时股东会会议议案 | 6 | | 议案一：关于补选公司第二届董事会非独立董事的议案 6 | | 上海毕得医药科技股份有限公司 2025 年第五次临时股东会会议资料 上海毕得医药科技股份有限公司 2025 年第五次临时股东会会议须知 为了维护全体股东的合法权益，确保股东会的正常秩序和议事效率，保证大 会的顺利进行，根据《中华人民共和国公司法》《中华人民共和国证券法》《上 市公司股东会规则》以及《上海毕得医药科技股份有限公司章程》等相关规定， 上海毕得医药科技股份有限公司（以下简称"公司"或"毕得医药"）特制定股 东会会议须知： 一、为确认出席大会的股东或其代理人或其他出席者的出席资格，会议工作 人员将对出席会议者的身份进行必要的核对工作，请被核对者给予配 ...

Core Viewpoint - The medical services sector experienced a decline of 2.05% on December 2, with Yinosh leading the drop. The Shanghai Composite Index closed at 3897.71, down 0.42%, while the Shenzhen Component Index closed at 13056.7, down 0.68% [1]. Group 1: Market Performance - The medical services sector saw significant individual stock movements, with ST Zhongzhu closing at 2.95, up 3.51%, and Yinosh closing at 41.58, down 7.27% [1][2]. - The total net outflow of main funds in the medical services sector was 9.53 billion yuan, while retail investors saw a net inflow of 6.87 billion yuan [2][3]. Group 2: Individual Stock Analysis - ST Zhongzhu had a trading volume of 1.27 million hands and a transaction amount of 372 million yuan, while Yinosh had a trading volume of 19,500 hands and a transaction amount of 82.48 million yuan [1][2]. - The stock performance varied, with some stocks like Innovation Medical and Dean Diagnostics showing slight declines, while others like ST Zhongzhu showed gains [1][2]. Group 3: Fund Flow Analysis - Main funds showed a net inflow in stocks like Innovation Medical (63.01 million yuan) and Dean Diagnostics (20.61 million yuan), while there were net outflows in several other stocks [3]. - Retail investors contributed to the net inflow in stocks like Innovation Medical and Dean Diagnostics, despite overall sector outflows [3].